Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: the IFM experience on 2316 patients (Q39210735)
Jump to navigation
Jump to search
scientific article published on 11 April 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: the IFM experience on 2316 patients |
scientific article published on 11 April 2014 |
Statements
1 reference
Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: the IFM experience on 2316 patients (English)
1 reference
Thierry Facon
Philippe Moreau
Margaret Macro
Xavier Delbrel
Anne-Marie Stoppa
Benjamin Hebraud
Marie-Lorraine Chretien
Laurent Garderet
Sabine Brechignac
Gerald Marit
Mamoun Dib
Marc Wetterwald
Pascal Lenain
Laurent Voillat
Laurence Legros
Lionel Karlin
Thierry Lamy
Catherine Sebban
Frédérique Orsini-Piocelle
Valérie Cances-Lauwers
Bruno Royer
Denis Caillot
Cyrille Hulin
1 reference
1 reference